Summary

The Refurbished medical equipment market is projected to reach USD 24.41 Billion by 2029 from USD 16.93 in 2024, growing at a CAGR of 7.6% during the forecast period. The market is growing due to numerous factors.Increasing cases of infectious diseases, and regular advancements in Refurbished medical equipment drives this market. Rising expenditure in research and development and increase in application of biomarker profiling to detect diseases are other factors. Additionally, the market growth is affected by inclusion of Refurbished medical equipment with artificial intelligence.

“Medical imaging equipment to account for largest market share in 2023.”
A market is being formed for the refurbished medical imaging equipment owing to the increased sectored investments in private healthcare and emerging health infrastructures in developing economies. This makes refurbished systems like CT and X-ray machines affordable for new hospitals within emerging markets. Multi-dimensional forces such as economic elements, technological advancement, and regulatory frameworks encourage the growth of refurbished medical imaging equipment markets globally. Organizations dealing in refurbished medical imaging adhere to many regulations since these should guarantee that they meet or exceed the industry standards. Siemens Healthineers and GE Healthcare, for instance, provides refurbished MRI systems and CT scanners with warranties and certifications.

“Hospitals to hold largest share in the market.”
Various significant factors are propelling the growth of hospitals in the refurbished medical equipment industry. Numerous causes like economic pressures, technological advancements, and healthcare-related factors have encouraged the global growth of refurbished medical equipment in hospitals and surgical centers. Some of these causes include rising prices for new medical devices, the increasing requirement for cost-effective health-care solutions, and improvements in refurbishment methods. A good example of commonly utilized ultrasound windows is in rural areas or areas with low budgets. They provide high performance while being cheaper than new equipment; thus, they ensure diagnostic services continue even at low-resource settings.

"North America to register largest share in 2023."
The largest share was hold by North America in 2023. North America comprise US and Canada.
Reduced costs are one of the most major factors attracting North America towards refurbished medical equipment. Genuinely refurbished equipment serves as a shake quality alternative to new devices, enabling hospitals to make do even with very restricted budgets. Above all, pressure from the government for sustainability and the reduction of electronic waste in North America adds importance to refurbishing medical equipment. It promises to nullify the environmental impact of thrown-up devices and at the same time promote circular economies. In North America, refurbished medical equipment stands under very stringent regulatory requirements (like FDA in the U.S.). The quality and safety assured make healthcare providers much more confident in purchasing refurbished devices. As well, hospitals and clinics grow their medical arms without making huge financial outlays for the refurbished option to fulfill the high demand for urine ultrasound machines in North America.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3– 20%
• By Designation: C-level-- 35%, Director-level–25%, and Others–40%
• By Region: North America–40%, Europe-30%, Asia Pacific–20%, Latin America - 5%, Middle East & Africa- 5%

Prominent players in the Refurbished medical equipment market include GE Healthcare (US), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Block Imaging International,Inc. (US), Canon Medical Systems Corp. (Japan), Soma Technology, Inc. (US), and Avante Health Solutions (US), Mindray Medical International (China), Dragerwerk AG & Co. KGAA (Germany), Whittemore Enterprises (U.S.), Stryker (US), Directmed Parts & Services (US), Medline Industries (U.S.), Traco Medical (U.S.), Nihon Kohden Corporation (Japan), Master Medical Equipment (U.S.), and Everx Pvt. Ltd. (US).

Research Coverage
The report comprise segmentation that includes end users, products, applications, and geographic regions. It also discusses the key drivers, restraints, opportunities, and challenges affecting the growth of the Refurbished medical equipment market. The research offers stakeholders an assessment of market potential and challenges, with a focus on key players and competitive landscapes. Additionally, micromarkets are assessed according to their overall to the refurbished medical equipment sector, growth patterns, and potential. The analysis estimates increase in market segment revenues, focusing on five regions.
Key Benefits of Buying the Report:
This research aids new and existing players in the Refurbished medical equipment market to assess the sustainability of their investments by offering detailed information. It offers a dataset to assist in making key decisions. The main advantage of this report includes risk evaluation and offering direction for investment decisions. Market segmentation as per the end-users and geographical areas is offered in the study, that provides analysis and insights. It also provides trends, obstacles, opportunities, and drivers, giving stakeholders the information they need to make strategic decisions.

The report provides the insights on the following pointers:

Analysis of the key drivers, restraints, opportunities, and challenges impacting the Refurbished medical equipment market growth: rise in prevalence of chronic diseases, cost efficiency as compared to new medical equipment; negative perception for refurbished product quality; updated technology with software integration and regulatory support helps refurbished medical equipment to grow in the market.

Product Development/Innovation: Overview of technologies, research & development ventures and launch of innovative product & service for the refurbished medical equipment industry.

Market Development: Details related to profitable markets: this research discussees the Refurbished medical equipment business in numerous regions.

Market Diversification: Detailed understanding of advanced products, unexplored areas, latest developments, and investment in the market.

Competitive Assessment: Detailed analysis of market share, services and products offered and key strategies adopted by prominent players such as GE Healthcare (US), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Avante Health Solutions (US), Soma Technology, Inc. (US) and Canon Medical Systems Coproration(Japan).

ページTOPに戻る

Table of Contents

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 35
1.3.1 SEGMENTS COVERED & GEOGRAPHICAL SPREAD 35
1.3.2 INCLUSIONS & EXCLUSIONS 36
1.3.3 YEARS CONSIDERED 37
1.3.4 CURRENCY CONSIDERED 37
1.4 MARKET STAKEHOLDERS 38
1.5 SUMMARY OF CHANGES 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH DATA 39
2.2 RESEARCH DESIGN 40
2.2.1 SECONDARY RESEARCH 40
2.2.1.1 Key secondary sources 40
2.2.1.2 Key objectives of secondary research 41
2.2.1.3 Key data from secondary sources 42
2.2.2 PRIMARY RESEARCH 42
2.2.2.1 Key primary sources 43
2.2.2.2 Key objectives of primary research 43
2.2.2.3 Key industry insights 44
2.2.2.4 Breakdown of primaries 44
2.3 MARKET SIZE ESTIMATION 45
2.3.1 BOTTOM-UP APPROACH 46
2.3.1.1 Company revenue estimation approach 47
2.3.1.2 Customer-based market estimation 47
2.3.2 TOP-DOWN APPROACH 48
2.3.2.1 Primary interviews 49
2.4 MARKET GROWTH FORECAST 49
2.5 DATA TRIANGULATION 50
2.6 MARKET SHARE ASSESSMENT 51
2.7 STUDY ASSUMPTIONS 51
2.8 GROWTH ASSUMPTIONS 51
2.9 RISK ASSESSMENT 53
2.10 RESEARCH LIMITATIONS 54
3 EXECUTIVE SUMMARY 55
4 PREMIUM INSIGHTS 60
4.1 REFURBISHED MEDICAL EQUIPMENT MARKET OVERVIEW 60
4.2 REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 61
4.3 REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY AND
END USER, 2023 (USD MILLION) 62
4.4 GEOGRAPHIC SNAPSHOT OF REFURBISHED MEDICAL EQUIPMENT MARKET 63
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
5.2.1 DRIVERS 65
5.2.1.1 Increased need for affordable and advanced
diagnostic imaging equipment 65
5.2.1.2 Better warranties and service agreements for refurbished equipment 65
5.2.1.3 Increased focus on environmental sustainability in healthcare sector 66
5.2.1.4 Rising healthcare costs and need for cost-saving alternatives 66
5.2.2 RESTRAINTS 67
5.2.2.1 Lesser reliability in high-regulated sectors and lack of standardized refurbishment processes 67
5.2.2.2 Availability of cost-effective new medical equipment 67
5.2.3 OPPORTUNITIES 68
5.2.3.1 Increased acceptability of refurbished equipment by large hospitals
and healthcare systems 68
5.2.3.2 Expansion of online marketplaces and global logistics networks 68
5.2.4 CHALLENGES 69
5.2.4.1 Lack of uniform refurbishment standards for medical equipment 69
5.2.4.2 Rapid innovation in medical technology 69
5.3 VALUE CHAIN ANALYSIS 70
5.4 PORTER’S FIVE FORCES ANALYSIS 72
5.4.1 THREAT OF NEW ENTRANTS 73
5.4.2 THREAT OF SUBSTITUTES 73
5.4.3 BARGAINING POWER OF SUPPLIERS 73
5.4.4 BARGAINING POWER OF BUYERS 73
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 74
5.5 KEY STAKEHOLDERS & BUYING CRITERIA 74
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS 74
5.5.2 KEY BUYING CRITERIA 75
5.6 PATENT ANALYSIS 76
5.6.1 LIST OF MAJOR PATENTS 77
5.7 KEY CONFERENCES & EVENTS, 2024–2026 79
5.8 TRADE DATA ANALYSIS 80
5.8.1 IMPORT DATA FOR HS CODE 9018 80
5.8.2 EXPORT DATA FOR HS CODE 9018 81
5.9 PRICING ANALYSIS 81
5.9.1 AVERAGE SELLING PRICE TREND OF REFURBISHED MEDICAL EQUIPMENT,
BY REGION, 2021–2023 81
5.9.2 AVERAGE SELLING PRICE TREND OF REFURBISHED MEDICAL IMAGING EQUIPMENT, BY PRODUCT, 2021–2023 85
5.9.3 AVERAGE SELLING PRICE OF REFURBISHED MEDICAL EQUIPMENT,
BY KEY PLAYER, 2023 88
5.10 UNMET NEEDS & KEY PAIN POINTS 89
5.11 ECOSYSTEM ANALYSIS 90
5.12 SUPPLY CHAIN ANALYSIS 91
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 93
5.14 TECHNOLOGY ANALYSIS 93
5.14.1 KEY TECHNOLOGIES 93
5.14.1.1 Portable and point-of-care medical devices 93
5.14.1.2 Diagnostic imaging systems 94
5.14.1.3 Laboratory, surgical, and therapeutic equipment 94
5.14.2 COMPLEMENTARY TECHNOLOGIES 94
5.14.2.1 AI-powered predictive analytics 94
5.14.2.2 Digital connectivity and telemedicine technologies 95
5.14.2.3 Remote monitoring technologies 95
5.14.3 ADJACENT TECHNOLOGIES 95
5.14.3.1 Robotics and automation technologies 95
5.15 REGULATORY LANDSCAPE 96
5.15.1 REGULATORY FRAMEWORK 96
5.15.1.1 North America 96
5.15.1.1.1 US 96
5.15.1.1.2 Canada 96
5.15.2 EUROPE 97
5.15.3 ASIA PACIFIC 98
5.15.3.1 Japan 98
5.15.3.2 China 99
5.15.3.3 India 99
5.15.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
5.16 INVESTMENT & FUNDING SCENARIO 102
5.17 REIMBURSEMENT SCENARIO ANALYSIS 104
5.18 IMPACT OF AI/GEN AI ON REFURBISHED MEDICAL EQUIPMENT MARKET 105
6 REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT 106
6.1 INTRODUCTION 107
6.2 MEDICAL IMAGING EQUIPMENT 108
6.2.1 CT SCANNERS 113
6.2.1.1 Cost-effectiveness and favorable government regulations to
propel segment growth 113
6.2.2 MRI MACHINES 116
6.2.2.1 Need to reduce healthcare costs and increase focus on technological advancements to aid market growth 116
6.2.3 X-RAY MACHINES 119
6.2.3.1 Availability of flexible leasing and financing options to spur adoption 119
6.2.4 NUCLEAR IMAGING SYSTEMS 122
6.2.4.1 Public-private investments for purchasing new high-end nuclear imaging systems to limit market growth 122
6.2.5 ULTRASOUND SYSTEMS 125
6.2.5.1 Economic downturn and decreased reimbursement for new equipment in developed countries to drive market 125
6.2.6 PET/SPECT SYSTEMS 128
6.2.6.1 Reduced electronic wastage to support sustainability
initiatives in healthcare 128
6.2.7 MAMMOGRAPHY SYSTEMS 131
6.2.7.1 Rising number of breast cancer cases and decreasing cost of refurbished mammography systems to augment market growth 131
6.3 OPERATING ROOM & SURGICAL EQUIPMENT 135
6.3.1 ANESTHESIA MACHINES 139
6.3.1.1 Long waiting times for new equipment delivery to support segment growth 139
6.3.2 ELECTROSURGICAL UNITS 141
6.3.2.1 Hospital budget limitations and focus on minimally invasive surgeries to promote segment growth 141
6.3.3 OPERATING ROOM TABLES & LIGHTS 144
6.3.3.1 Low financial capabilities of healthcare organizations in emerging economies to boost adoption 144
6.3.4 SURGICAL DISPLAYS 147
6.3.4.1 High fluctuation in raw material and display panel pricing to propel adoption in healthcare settings 147
6.3.5 OTHER OPERATING ROOM & SURGICAL EQUIPMENT 151
6.4 PATIENT MONITORS 154
6.4.1 MULTIPARAMETER MONITORS 159
6.4.1.1 Increased use of home patient monitoring and low prices compared to mid- and high-acuity monitors to drive segment 159
6.4.2 FETAL MONITORS 162
6.4.2.1 Increasing prevalence of obstetric complications and preterm births to fuel adoption 162
6.4.3 ELECTROCARDIOGRAPHY DEVICES 166
6.4.3.1 Wide applications of ECG devices in cardiovascular diseases
to drive market 166
6.4.4 PULSE OXIMETERS 169
6.4.4.1 Introduction of low-cost single-use pulse oximeters to limit market growth 169
6.4.5 CARDIAC MONITORS 173
6.4.5.1 Need to reduce healthcare costs and high demand for home monitoring to support market growth 173
 
6.4.6 NON-INVASIVE BLOOD PRESSURE MONITORS 176
6.4.6.1 Growing health awareness and increasing incidence of cardiovascular diseases to propel segment growth 176
6.4.7 OTHER PATIENT MONITORS 179
6.5 CARDIOLOGY EQUIPMENT 183
6.5.1 DEFIBRILLATORS 187
6.5.1.1 Increasing prevalence of CVDs in low-income countries to drive adoption of refurbished defibrillators 187
6.5.2 HEART-LUNG MACHINES 190
6.5.2.1 Rising number of cardiac surgeries to support segment growth 190
6.5.3 OTHER CARDIOLOGY EQUIPMENT 193
6.6 UROLOGY EQUIPMENT 197
6.6.1 DIALYSIS MACHINES 200
6.6.1.1 Development of low-cost dialysis products to limit market growth 200
6.6.2 LITHOTRIPSY DEVICES 203
6.6.2.1 Increasing cases of kidney and ureteric stones to increase demand for refurbished lithotripsy devices 203
6.7 NEUROLOGY EQUIPMENT 206
6.7.1 EMG MACHINES 211
6.7.1.1 Use of EMG nerve monitoring for intraoperative applications to
fuel segment growth 211
6.7.2 EEG MACHINES 213
6.7.2.1 Reimbursement cuts to increase adoption of refurbished EEG machines 213
6.8 INTENSIVE CARE EQUIPMENT 216
6.8.1 VENTILATORS 221
6.8.1.1 Improved refurbishment techniques for upgrading used
ventilators to drive growth 221
6.8.2 INFANT INCUBATORS & WARMERS 224
6.8.2.1 High global birthrate and increasing number of neonates requiring additional medical intervention to fuel segment growth 224
6.9 INTRAVENOUS THERAPY SYSTEMS 228
6.9.1 INCREASING NUMBER OF SURGICAL PROCEDURES AND FREQUENT
PRODUCT RECALLS TO SUPPORT MARKET GROWTH 228
6.10 ENDOSCOPY EQUIPMENT 232
6.10.1 RISING DEMAND FOR ENDOSCOPY IN DETECTING CHRONIC DISEASES TO SUPPORT MARKET GROWTH 232
6.11 OTHER MEDICAL EQUIPMENT 236
7 REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION 241
7.1 INTRODUCTION 242
7.2 CARDIOLOGY DIAGNOSTIC APPLICATIONS 244
7.2.1 INCREASING INCIDENCE OF CARDIOVASCULAR AND CARDIO-PULMONARY DISORDERS TO DRIVE MARKET 244
 
7.3 UROLOGY DIAGNOSTIC APPLICATIONS 245
7.3.1 LOW BUDGET AVAILABILITY FOR PROCURING NEW UROLOGICAL
EQUIPMENT TO AID MARKET GROWTH 245
7.4 NEUROLOGY DIAGNOSTIC APPLICATIONS 246
7.4.1 BUDGET CONSTRAINTS TO INCREASE DEMAND FOR REFURBISHED MEDICAL EQUIPMENT AND STRATEGIC RESOURCE ALLOCATION 246
7.5 ORTHOPEDIC DIAGNOSTIC APPLICATIONS 247
7.5.1 GROWING GERIATRIC POPULATION AND RISING INCIDENCE OF TARGET DISEASES TO AID MARKET GROWTH 247
7.6 PHYSIOLOGY DIAGNOSTIC APPLICATIONS 248
7.6.1 RISING AWARENESS OF EARLY DISEASE DIAGNOSIS AND GROWING FOCUS ON HEALTHY LIFESTYLES TO AUGMENT MARKET GROWTH 248
7.7 EMERGENCY MEDICINE DIAGNOSTIC APPLICATIONS 249
7.7.1 INCREASING NUMBER OF NEONATES IN INTENSIVE CARE UNITS TO
PROPEL MARKET GROWTH 249
7.8 ONCOLOGY DIAGNOSTIC APPLICATIONS 250
7.8.1 HIGH INCIDENCE OF MALIGNANCIES AND INCREASED COST OF NEW MEDICAL IMAGING EQUIPMENT TO FUEL MARKET GROWTH 250
7.9 OB/GYNECOLOGY DIAGNOSTIC APPLICATIONS 251
7.9.1 INCREASING NUMBER OF MATERNITY CENTERS AND DIAGNOSTIC CLINICS TO SUPPORT MARKET GROWTH 251
7.10 OTHER DIAGNOSTIC APPLICATIONS 251
7.11 CARDIOLOGY THERAPEUTIC APPLICATIONS 252
7.11.1 LOW COST OF REFURBISHED EQUIPMENT AND HIGH-QUALITY CONTROL MEASURES BY OEMS TO DRIVE MARKET 252
7.12 UROLOGY THERAPEUTIC APPLICATIONS 253
7.12.1 BUDGETARY CONSTRAINTS IN PROCURING NEW EQUIPMENT TO
BOOST MARKET GROWTH 253
7.13 NEUROLOGY THERAPEUTIC APPLICATIONS 254
7.13.1 GROWING DEMAND FOR REFURBISHED ELECTROSURGERY AND SURGICAL EQUIPMENT TO PROPEL MARKET GROWTH 254
7.14 ORTHOPEDIC THERAPEUTIC APPLICATIONS 255
7.14.1 GROWING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE MARKET 255
7.15 PHYSIOLOGY THERAPEUTIC APPLICATIONS 256
7.15.1 DEARTH OF SKILLED SPECIALISTS IN EMERGING ECONOMIES TO
LIMIT MARKET GROWTH 256
7.16 EMERGENCY MEDICINE THERAPEUTIC APPLICATIONS 257
7.16.1 IMPROVED CRITICAL CARE INFRASTRUCTURE AND NEED FOR MORE ESSENTIAL CARE EQUIPMENT TO AUGMENT MARKET GROWTH 257
7.17 ONCOLOGY THERAPEUTIC APPLICATIONS 258
7.17.1 GROWING NUMBER OF NON-INVASIVE AND INTERVENTIONAL CANCER TREATMENT PROCEDURES TO AID MARKET SEGMENT 258
7.18 OB/GYNECOLOGY THERAPEUTIC APPLICATIONS 259
7.18.1 GROWING AWARENESS OF MATERNITY CARE IN EMERGING ECONOMIES TO
DRIVE MARKET GROWTH 259
7.19 OTHER THERAPEUTIC APPLICATIONS 260
8 REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER 261
8.1 INTRODUCTION 262
8.2 HOSPITALS 262
8.2.1 REFURBISHED EQUIPMENT TO IMPROVE HEALTHCARE INFRASTRUCTURE WITHOUT HIGH COST OF NEW DEVICES 262
8.3 DIAGNOSTIC IMAGING CENTERS 263
8.3.1 INCREASED NEED FOR IMAGING FOR EARLY DETECTION AND TREATMENT PLANNING TO SPUR MARKET GROWTH 263
8.4 ACADEMIC & GOVERNMENT ORGANIZATIONS 264
8.4.1 REFURBISHED EQUIPMENT TO OFFER FINANCIALLY VIABLE ALTERNATIVE AND REDUCE ELECTRONIC WASTAGE 264
8.5 AMBULATORY CARE CENTERS 265
8.5.1 INCREASING PREFERENCE FOR OUTPATIENT PROCEDURES TO
PROPEL MARKET GROWTH 265
8.6 OTHER END USERS 266
9 REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION 268
9.1 INTRODUCTION 269
9.2 NORTH AMERICA 269
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 270
9.2.2 US 274
9.2.2.1 US to dominate refurbished medical equipment market
during forecast period 274
9.2.3 CANADA 276
9.2.3.1 Budgetary constraints in hospitals and high demand for imaging procedures to aid adoption of refurbished medical equipment 276
9.3 EUROPE 277
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 278
9.3.2 GERMANY 282
9.3.2.1 Well-established pharmaceutical and R&D industry to
propel market growth 282
9.3.3 FRANCE 284
9.3.3.1 Increasing government pressure to reduce healthcare costs to
support market growth 284
9.3.4 UK 285
9.3.4.1 Rising preference for new equipment due to better safety and
compliance to limit market 285
9.3.5 ITALY 287
9.3.5.1 Supportive government policies and focus on value-based healthcare system to boost market growth 287
9.3.6 SPAIN 288
9.3.6.1 Technological advancements and improved healthcare infrastructure to aid market growth 288
9.3.7 REST OF EUROPE 290
 
9.4 ASIA PACIFIC 291
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 291
9.4.2 CHINA 297
9.4.2.1 Rapidly changing healthcare infrastructure and favorable government incentives to fuel market growth 297
9.4.3 JAPAN 299
9.4.3.1 High geriatric population and favorable health insurance system to propel market growth 299
9.4.4 INDIA 300
9.4.4.1 Low cost of refurbished equipment and need for alternatives to healthcare service to support market growth 300
9.4.5 AUSTRALIA 302
9.4.5.1 Preference for new equipment by government healthcare organizations to limit demand for refurbished medical equipment 302
9.4.6 SOUTH KOREA 303
9.4.6.1 Increased insurance coverage and free trade agreements with
US to support market growth 303
9.4.7 REST OF ASIA PACIFIC 305
9.5 LATIN AMERICA 305
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 306
9.5.2 BRAZIL 309
9.5.2.1 Growing disease burden and rising awareness about advanced
diagnostic and treatment procedures to support market growth 309
9.5.3 MEXICO 311
9.5.3.1 Favorable investment scenario for refurbished medical device manufacturers to drive market 311
9.5.4 REST OF LATIN AMERICA 312
9.6 MIDDLE EAST & AFRICA 313
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 314
9.6.2 GCC COUNTRIES 317
9.6.2.1 Advancements in healthcare infrastructure and increased focus on personalized medicines to fuel market growth 317
9.6.3 REST OF MIDDLE EAST & AFRICA 318
10 COMPETITIVE LANDSCAPE 320
10.1 INTRODUCTION 320
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 320
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
REFURBISHED MEDICAL EQUIPMENT MARKET 320
10.3 REVENUE ANALYSIS, 2019–2023 322
10.4 MARKET SHARE ANALYSIS, 2023 323
10.4.1 REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET SHARE,
BY KEY PLAYER, 2023 323
 
10.4.2 REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET SHARE,
BY KEY PLAYER, 2023 323
10.4.3 REFURBISHED PATIENT MONITORS MARKET SHARE, BY KEY PLAYER, 2023 324
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 326
10.5.1 STARS 326
10.5.2 EMERGING LEADERS 326
10.5.3 PERVASIVE PLAYERS 326
10.5.4 PARTICIPANTS 326
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 328
10.5.5.1 Company footprint 328
10.5.5.2 Region footprint 329
10.5.5.3 Product footprint 330
10.5.5.4 Application footprint 331
10.5.5.5 End-user footprint 332
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 333
10.6.1 PROGRESSIVE COMPANIES 333
10.6.2 RESPONSIVE COMPANIES 333
10.6.3 DYNAMIC COMPANIES 333
10.6.4 STARTING BLOCKS 333
10.6.5 COMPANY BENCHMARKING: STARTUPS/SMES, 2023 335
10.7 COMPANY VALUATION & FINANCIAL METRICS 337
10.8 PRODUCT/BRAND COMPARISON 338
10.9 COMPETITIVE SCENARIO 339
10.9.1 PRODUCT LAUNCHES 339
10.9.2 DEALS 340
11 COMPANY PROFILES 341
11.1 KEY PLAYERS 341
11.1.1 GE HEALTHCARE 341
11.1.1.1 Business overview 341
11.1.1.2 Products offered 343
11.1.1.3 Recent developments 345
11.1.1.3.1 Product launches 345
11.1.1.3.2 Deals 345
11.1.1.3.3 Expansions 345
11.1.1.4 MnM view 346
11.1.1.4.1 Key strengths 346
11.1.1.4.2 Strategic choices 346
11.1.1.4.3 Weaknesses & competitive threats 346
11.1.2 PHILIPS HEALTHCARE 347
11.1.2.1 Business overview 347
11.1.2.2 Products offered 348
11.1.2.3 Recent developments 350
11.1.2.3.1 Product launches 350
11.1.2.3.2 Deals 351
11.1.2.3.3 Other developments 351
11.1.2.4 MnM view 351
11.1.2.4.1 Key strengths 351
11.1.2.4.2 Strategic choices 352
11.1.2.4.3 Weaknesses & competitive threats 352
11.1.3 SIEMENS HEALTHINEERS AG 353
11.1.3.1 Business overview 353
11.1.3.2 Products offered 354
11.1.3.3 Recent developments 356
11.1.3.3.1 Deals 356
11.1.3.4 MnM view 356
11.1.3.4.1 Key strengths 356
11.1.3.4.2 Strategic choices 356
11.1.3.4.3 Weaknesses & competitive threats 356
11.1.4 STRYKER 357
11.1.4.1 Business overview 357
11.1.4.2 Products offered 358
11.1.4.3 MnM view 359
11.1.4.3.1 Key strengths 359
11.1.4.3.2 Strategic choices 359
11.1.4.3.3 Weaknesses & competitive threats 359
11.1.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 360
11.1.5.1 Business overview 360
11.1.5.2 Products offered 361
11.1.5.3 Recent developments 361
11.1.5.3.1 Product launches 361
11.1.5.4 MnM view 361
11.1.5.4.1 Key strengths 361
11.1.5.4.2 Strategic choices 362
11.1.5.4.3 Weaknesses & competitive threats 362
11.1.6 CANON MEDICAL SYSTEMS CORPORATION 363
11.1.6.1 Business overview 363
11.1.6.2 Products offered 365
11.1.6.3 Recent developments 365
11.1.6.3.1 Product launches 365
11.1.6.3.2 Deals 365
11.1.7 DRÄGERWERK AG & CO. KGAA 366
11.1.7.1 Business overview 366
11.1.7.2 Products offered 367
11.1.8 NIHON KOHDEN CORPORATION 368
11.1.8.1 Business overview 368
11.1.8.2 Products offered 369
11.1.8.3 Recent developments 370
11.1.8.3.1 Deals 370
11.1.9 OLYMPUS CORPORATION 371
11.1.9.1 Business overview 371
11.1.9.2 Products offered 373
11.1.10 AVANTE HEALTH SOLUTIONS 374
11.1.10.1 Business overview 374
11.1.10.2 Products offered 375
11.1.11 SOMA TECH INTL. 376
11.1.11.1 Business overview 376
11.1.11.2 Products offered 376
11.1.12 EVERX 378
11.1.12.1 Business overview 378
11.1.12.2 Products offered 378
11.1.13 RADIOLOGY ONCOLOGY SYSTEMS 379
11.1.13.1 Business overview 379
11.1.13.2 Products offered 379
11.1.13.3 Recent developments 380
11.1.13.3.1 Deals 380
11.1.14 MASTER MEDICAL EQUIPMENT 381
11.1.14.1 Business overview 381
11.1.14.2 Products offered 381
11.1.15 FAIR-MEDICAL INC. 382
11.1.15.1 Business overview 382
11.1.15.2 Products offered 382
11.1.16 FUTURE HEALTH CONCEPTS 383
11.1.16.1 Business overview 383
11.1.16.2 Products offered 383
11.1.17 HILDITCH GROUP LTD. 384
11.1.17.1 Business overview 384
11.1.17.2 Products offered 385
11.1.18 BLOCK IMAGING, INC. 386
11.1.18.1 Business overview 386
11.1.18.2 Products offered 386
11.1.18.3 Recent developments 387
11.1.18.3.1 Deals 387
 
11.2 OTHER PLAYERS 388
11.2.1 NATIONWIDE IMAGING SERVICES 388
11.2.2 PACIFIC HEALTHCARE IMAGING 389
11.2.3 VENTURE MEDICAL REQUIP 390
11.2.4 DESERT TECH MEDICAL SYSTEMS INC. 391
11.2.5 HI-TECH INTERNATIONAL 392
11.2.6 AMBER DIAGNOSTICS 393
11.2.7 WHITTEMORE ENTERPRISES 394
11.2.8 TRACO MEDICAL INC. 395
11.2.9 US MED-EQUIP 396
11.2.10 US MEDICAL SYSTEMS 397
11.2.11 MEDLINE INDUSTRIES, INC. 398
11.2.12 DIRECTMED IMAGING 399
11.2.13 AGITO MEDICAL 400
12 APPENDIX 401
12.1 DISCUSSION GUIDE 401
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 407
12.3 CUSTOMIZATION OPTIONS 409
12.4 RELATED REPORTS 410
12.5 AUTHOR DETAILS 411